Video

Unlocking the Future of Allogeneic Cell Therapy for Oncology | Audience Q&A

Source: Cell & Gene

Cokey Nguyen, Ph.D. EVP, Chief Scientific & Technical Officer at Atara Bio and Loren Wagner, COO at Poseida Therapeutics answer our questions submitted by our audience during the presentation. They provided detailed responses to questions about the potential risks of CAR-T therapy, screening criterial for donor material, comparability, and more.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests: